Table 3. Characteristics and outcome of the surgery.
Characteristics and outcome | n (%) | ||
---|---|---|---|
Type of surgery: 43 cases underwent surgery following exemestane administration | |||
Conservative surgery | 24 of 43 (55.8) | 24 of 54 (44.8) | |
Mastectomy | 19 of 43 (44.2) | 19 of 54 (35.2) | |
Pathologic response | |||
Response | Local | Response | Axilla |
CR G5 | 1 | CR D | 1 |
PR G3+G4 | 23 | CR D | 2 |
PR C | 9 | ||
No response B | 3 | ||
Not performed | 9 | ||
No Response G1+G2 | 19 | PR C | 2 |
No response B | 8 | ||
Not performed | 9 |
CR=complete response; PR=partial response.
Pathologic response assessment according Miller and Payne classification (Walker et al, 1999).
G5: absence of residual infiltrating tumour cells.
G4: marked disappearance of invasive tumour cells; only small clusters of widely dispersed cells could be detected.
G3: considerable reduction in tumour cells.
G2: mild loss of invasive tumour cells, but overall cellularity still high.
G1: no reduction in overall numbers as compared with pre-treatment biopsy.
B: lymph node positive with malignant cells.
C: lymph node still positive, but with evidence of some regression.
D: lymph node without metastases, previously were positive.
In a total of 18 patients, axilla lymphadenectomy was not performed (decision of the surgical team or of the patient).